HCV Viral Load



•Baseline HCV RNA Level of 400,000 Is Optimal Cut-off Point to Differentiate Low and High Probability of SVR  11/07/06
•HCV RNA Negativity after 12 Weeks of Therapy Is the Best Predictor of SVR in Re-Treatment of Non-Responders: The EPIC3 Program  11/03/06
•Risk Factors for Relapse in Patients with High Viral Load and Genotype 3 Hepatitis C in the WIN-R Trial  11/03/06
•Higher Fixed Doses of Both Pegasys and Ribavirin May Benefit Difficult-to-Cure Genotype 1 Patients with High Viral Load and Above Average Body Weight  11/03/06
•Baseline HCV RNA of 400,000 Best Predicts SVR and Relapse Rates in Patients Treated with Pegasys plus Ribavirin  11/03/06



Google_______________


 

 

 

 

 

 

 

 

 

 

 

 

 

 


Conference
Main Page

Hepatitis C
FDA-Approved
Treatments

Monotherapies
Intron A
Roferon
Infergen
Pegasys
PEG-Intron

Combination
 Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Hepatitis B
FDA-Approved
Treatments

Baraclude
 Epivir-HBV
 Hepsera
 Intron A
 Pegasys
 Tyzeka